UBS ASSET MANAGEMENT AMERICAS INC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,404,217
+57.0%
34,400
+38.5%
0.00%0.0%
Q2 2023$1,531,8220.0%24,8350.0%0.00%0.0%
Q1 2023$1,531,822
-26.3%
24,835
-7.9%
0.00%0.0%
Q4 2022$2,078,961
-99.8%
26,954
+7.8%
0.00%0.0%
Q3 2022$1,115,634,000
+32.0%
25,003
+13.3%
0.00%
Q2 2022$845,167,000
-11.1%
22,067
-3.9%
0.00%
Q1 2022$950,273,000
+9.6%
22,9590.0%0.00%
Q4 2021$867,392,000
+14.6%
22,9590.0%0.00%
Q3 2021$756,729,000
-59.4%
22,959
-16.9%
0.00%
-100.0%
Q2 2021$1,863,582,000
+32.5%
27,625
+11.2%
0.00%0.0%
Q1 2021$1,406,837,000
-36.1%
24,847
-8.1%
0.00%0.0%
Q4 2020$2,203,194,000
+11.7%
27,043
-2.3%
0.00%0.0%
Q3 2020$1,971,701,000
-11.7%
27,673
+2.0%
0.00%0.0%
Q2 2020$2,232,092,000
+105.2%
27,128
+46.7%
0.00%0.0%
Q1 2020$1,087,943,000
-54.8%
18,493
-20.7%
0.00%0.0%
Q4 2019$2,409,115,000
+798.7%
23,308
+76.0%
0.00%
Q3 2019$268,058,000
-55.2%
13,244
-43.0%
0.00%
Q2 2019$598,095,00023,2270.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders